{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:31:32Z","timestamp":1769153492548,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.leukres.2023.107401","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:59:53Z","timestamp":1695466793000},"page":"107401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-4291","authenticated-orcid":false,"given":"Afshin","family":"Shameli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Dharmani-Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meer-Taher","family":"Shabani-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107401_bib1","unstructured":"Swerdlow S.H., Campo E., Harris N.L., Pileri S.A. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: International Agency for Research on Cancer; 2017."},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2018.05.015","article-title":"The current approach to the diagnosis of myelodysplastic syndromes.","volume":"56","author":"Weinberg","year":"2019","journal-title":"Semin Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2023.107401_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-014-2252-4","article-title":"Interobserver variance in myelodysplastic syndromes with less than 5% bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2% blasts","volume":"94","author":"Font","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2023.107401_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.leukres.2018.04.003","article-title":"Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome","volume":"69","author":"Sasada","year":"2018","journal-title":"Leuk. Res"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.leukres.2023.107401_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2023.107401_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2023.107401_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cll.2017.07.006","article-title":"Flow cytometric assessment of chronic myeloid neoplasms","volume":"37","author":"Shi","year":"2017","journal-title":"Clin. Lab Med"},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cyto.b.20041","article-title":"Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes","volume":"64","author":"Cherian","year":"2005","journal-title":"Cytom. B Clin. Cytom."},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk. Res"},{"issue":"3","key":"10.1016\/j.leukres.2023.107401_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"van de Loosdrecht","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2023.107401_bib13","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2023.107401_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-08-239749","article-title":"Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment","volume":"115","author":"Westers","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2023.107401_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.leukres.2023.107401_bib16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088706","article-title":"Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.leukres.2023.107401_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cytob.21160","article-title":"Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes","volume":"86","author":"Alhan","year":"2014","journal-title":"Cytom. B Clin. Cytom."},{"issue":"4","key":"10.1016\/j.leukres.2023.107401_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2014.112755","article-title":"Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"100","author":"Bardet","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.leukres.2023.107401_bib20","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.3324\/haematol.2014.115725","article-title":"Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring","volume":"100","author":"Oelschlaegel","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.leukres.2023.107401_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/leu.2015.295","article-title":"The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system","volume":"30","author":"Alhan","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2016.147843","article-title":"Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes","volume":"102","author":"Cremers","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2016.147835","article-title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","volume":"102","author":"Westers","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2023.107401_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ajcp\/aqz196","article-title":"CD177 enhances the detection of myelodysplastic syndrome by flow cytometry","volume":"153","author":"Alayed","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cyto.b.22105","article-title":"Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group","volume":"104","author":"Kern","year":"2023","journal-title":"Cytom. B Clin. Cytom."},{"issue":"9","key":"10.1016\/j.leukres.2023.107401_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2014.191","article-title":"Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International\/European LeukemiaNet Working Group for Flow Cytometry in MDS","volume":"28","author":"Porwit","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.leukres.2023.107401_bib27","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2023.107401_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cyto.b.21333","article-title":"Application of flow cytometry for myelodysplastic syndromes: pitfalls and technical considerations","volume":"90","author":"Alhan","year":"2016","journal-title":"Cytom. B Clin. Cytom."},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cyto.b.22046","article-title":"Flow cytometric analysis of myelodysplasia: pre-analytical and technical issues-recommendations from the European LeukemiaNet","volume":"104","author":"van der Velden","year":"2023","journal-title":"Cytom. B Clin. Cytom."},{"issue":"3","key":"10.1016\/j.leukres.2023.107401_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1309\/AJCP73QSLLYDEGXK","article-title":"Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms","volume":"142","author":"Jevremovic","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.leukres.2023.107401_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cyto.b.21983","article-title":"Exploring blast composition in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy","volume":"100","author":"Shameli","year":"2021","journal-title":"Cytom. B Clin. Cytom."},{"issue":"10","key":"10.1016\/j.leukres.2023.107401_bib32","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood-2011-12-399683","article-title":"Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations","volume":"120","author":"Will","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107401_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197823","article-title":"Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes","volume":"13","author":"Ostendorf","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cyto.b.21519","article-title":"Visualization of cell composition and maturation in the bone marrow using 10-color flow cytometry and radar plots","volume":"94","author":"Jafari","year":"2018","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.leukres.2023.107401_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-023-01811-5","article-title":"Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression","author":"van Spronsen","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107401_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.730899","article-title":"Stem cells in myelodysplastic syndromes and acute myeloid leukemia: first cousins or unrelated entities?","volume":"11","author":"Joudinaud","year":"2021","journal-title":"Front Oncol."},{"issue":"12","key":"10.1016\/j.leukres.2023.107401_bib37","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcp\/aqab116","article-title":"Flow cytometric findings in clonal cytopenia of undetermined significance","volume":"157","author":"Nirmalanantham","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"issue":"25","key":"10.1016\/j.leukres.2023.107401_bib39","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2023.107401_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2023.107401_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cyto.b.21830","article-title":"Low-grade myelodysplastic syndromes with preserved CD34+ B-cell precursors (CD34+ hematogones)","volume":"98","author":"Chen","year":"2020","journal-title":"Cytom. B Clin. Cytom."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:54Z","timestamp":1758935094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623006665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":41,"alternative-id":["S0145212623006665"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107401","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107401"}}